HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: Role of infected blood donors as sentinel populations for molecular surveillance of HIV

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 387-392

  Alencar, Cecília S ^a,b   Sabino, Ester C ^b   Carvalho, Silvia M F ^c   Leao, Silvana C ^d   Carneiro Proietti, Anna B ^e   Capuani, Ligia ^f   Oliveira, Cláudia L ^g   Carrick, Danielle ^h   Birch, Rebecca J ^h   Gonçalez, Thelma T ⁱ   Keating, Sheila ⁱ   Swanson, Priscilla A ^j   Hackett Jr , John ^j   Busch, Michael P ⁱ  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HEMORIO   (Brazil)

^d HEMOPE   (Brazil)

^e Hemominas Foundation   (Brazil)

^f FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^g Academic of Pharmacy of Federal University São João Del Rei   (Brazil)

^h WESTAT   (United States)

ⁱ BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^j ABBOTT LABORATORIES   (United States)

more..

Author keywords

Blood donors; Brazil; Genotypes; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; BLOOD DONOR; BRAZIL; CASE STUDY; CONTROL; DISEASE SURVEILLANCE; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; THERAPY; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTI-HIV AGENTS; BASE SEQUENCE; BLOOD DONORS; BRAZIL; CASE-CONTROL STUDIES; DRUG RESISTANCE, VIRAL; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; QUESTIONNAIRES; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS, RNA; VIRAL LOAD;

EID: 84880195344     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828ff979     Document Type: Article

References (28)

1. Secretaria de Vigilância em Saúde, Dep de DST Ae HV, ed. Boletim Epidemiológico-Aids e DST. Brasilia, Brazil: Ministério da Saúde; 2011.
2. Morgado MG, Sabino EC, Shpaer EG, et al. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses. 1994;10:569-576.
3. Brindeiro RM, Diaz RS, Sabino EC, et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS. 2003;17:1063-1069.
4. Teixeira PR, Vitoria MA, Barcarolo J. Antiretroviral treatment in resource-poor settings: the Brazilian experience. AIDS. 2004;18(suppl 3):S5-S7.
5. Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675-1682.
6. Sethi AK, Celentano DD, Gange SJ, et al. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503-510.
7. Wensing AM, Boucher CA. Worldwide transmission of drug-resistant HIV. AIDS Rev. 2003;5:140-155.
8. Tang JW, Pillay D. Transmission of HIV-1 drug resistance. J Clin Virol. 2004;30:1-10.
9. Kleinman S, King MR, Busch MP, et al. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev. 2012;26:281-304; e1-e2.
10. Almeida-Neto C, Goncalez TT, Birch R, et al. Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a mul-ticenter case-control study using audio computer-assisted structured interviews. Vox Sang. Mar 20, 2013. [Epub ahead of print] Available at: http://onlinelibrary. wiley.com/doi/10.1111/vox.12028/abstract. Accessed May 20, 2013.
11. Carneiro-Proietti AB, Sabino EC, Sampaio D, et al. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion. 2010;50: 918-925.
12. Sabino EC, Goncalez TT, Carneiro-Proietti AB, et al. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil. Transfusion. 2012;52:870-879.
13. Barreto CC, Nishyia A, Araujo LV, et al. Trends in antiretroviral drug resistance and clade distributions among HIV-1-infected blood donors in Sao Paulo, Brazil. J Acquir Immune Defic Syndr. 2006; 41:338-341.
14. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.
15. Cavalcanti AM, Brito AM, Salustiano DM, et al. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco. Mem Inst Oswaldo Cruz. 2012;107:450-457.
16. Brigido LF, Nunes CC, Oliveira CM, et al. HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. AIDS Res Hum Retroviruses. 2007;23:1579-1586.
17. Gonzalez AM, Filho GJ, Pestana JO, et al. Effects of Eurocollins solution as aortic flush for the procurement of human pancreas. Transplantation. 2005;80:1269-1274.
18. Brigido LF, Ferreira JL, Almeida VC, et al. Southern Brazil HIV type 1 C expansion into the state of Sao Paulo, Brazil. AIDS Res Hum Retro-viruses. 2011;27:339-344.
19. Silveira J, Santos AF, Martínez AM, et al. Heterosexual transmission of human immunodeficiency virus type 1 subtype C in southern Brazil. J Clin Virol. 2012;54:36-41.
20. Sabino EC, Diaz RS, Brigido LF, et al. Distribution of HIV-1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil. AIDS. 1996;10: 1579-1584.
21. Luppi CG, Eluf-Neto J, Sabino E, et al. Late diagnosis of HIV infection in women seeking counseling and testing services in Sao Paulo, Brazil. AIDS Patient Care STDS. 2001;15:391-397.
22. Turchi MD, Diaz RS, Martelli CM, et al. Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J Acquir Immune Defic Syndr. 2002;30:527-532.
23. Brigido LF, Franco HM, Custodio RM, et al. Molecular characteristics of HIV type 1 circulating in Sao Paulo, Brazil. AIDS Res Hum Retroviruses. 2005;21:673-682.
24. Sprinz E, Netto EM, Patelli M, et al. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses. 2009;25:861-867.
25. Inocencio LA, Pereira AA, Sucupira MC, et al. Brazilian network for HIV drug resistance surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc. 2009;12:20.
26. Gonsalez CR, Alcalde R, Nishiya A, et al. Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. Virus Res. 2007;129:87-90.
27. Bermudez-Aza EH, Kerr LR, Kendall C, et al. Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil. J Acquir Immune Defic Syndr. 2011;57(suppl 3): S186-S192.
28. Sucupira MC, Caseiro MM, Alves K, et al. High levels of primary anti-retroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007;21:116-128.